Objection to Application by Dow for general release of GM maize: MON89034 X TC1507 x NK603 with the intention for cultivation in the entire region of South Africa

Objection

The ACB has played an essential watch-dog role on new GMO permits in South Africa for a decade now, adding substantially to the discourse about the scientific assessment of GMOs as well as about issues of socioeconomic impacts and democratic decisionmaking, through lodging substantive comments on at least 30 permit applications.

We are objecting to the general release of MON 89034 x TC1507 x NK603, due to concerns surrounding lack of safety to human and environmental health of this GM maize variety and its associated pesticides, glyphosate and glufosinate. This latest variety will serve to further increase exposure by the peoples of South Africa to yet more chemical pesticides, consolidate the corporate control of South Africa’s already corporatized food systems and entrench inequities and food insecurity.

Press Release: No benefit to imminent release of risky GM mosquitoes in Burkina Faso

Press release

Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release.

The project is set to apply for a permit to make an open release of 10,000 GM Anopheles gambiae mosquitoes: most likely in the village of Bana, west of Bobo Dioulasso.

The GM mosquitoes were exported from Imperial College in London to Burkina Faso in November 2016 and are currently in “contained use” facilities.